Latest Distribution Strategy News

Control Bionics reports a strong start to FY26 with nearly 10% revenue growth, expanded US reimbursement coverage, and advancing commercialization of its NeuroNode and NeuroStrip technologies.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

PolyNovo Limited has appointed Bruce Peatey as its new CEO, bringing extensive international healthcare experience to drive the company’s next growth phase. Peatey’s leadership is expected to accelerate PolyNovo’s expansion into new markets and outpatient care.

BlackRock Investment Management has released the estimated distribution components for its iShares S&P/ASX Dividend Opportunities ESG Screened ETF for the period ending 9 October 2025, highlighting key income sources and tax considerations.

360 Capital Mortgage REIT has announced an unfranked ordinary dividend of AUD 0.055 per unit for the September quarter, alongside the adoption of the Attribution Managed Investment Trust (AMIT) tax regime.

Pengana Global Private Credit Trust (ASX – PCX) has announced an $82 million entitlement and shortfall offer, inviting existing unitholders to subscribe for new units at $2.00 each, aiming to expand its diversified global private credit portfolio.

Garda Property Group has announced a quarterly distribution of AUD 0.02 per security for the period ending September 30, 2025, incorporating a notable non-cash capital gain component from a recent asset sale.

Computershare Limited has announced an ordinary dividend of AUD 0.48 per share for the half-year ending June 2025, alongside a confirmed Dividend Reinvestment Plan price of AUD 37.64.

IMEXHS reported a steady first half of FY25 with revenue up 4% and annualised recurring revenue climbing 11%, driven by strong adoption of its Aquila+ radiology platform and strategic capital raising.

Australian Dairy Nutritionals Group (ASX, AHF) reported a 14% revenue increase to $7.17 million for FY25, driven by a nearly fourfold surge in its infant formula segment, while reducing its net loss by 29%. The company remains debt-free and is expanding its footprint in China and Vietnam.

McPherson’s Limited reported a 3.9% revenue decline to $139 million in FY25 amid a strategic shift to a pharmacy wholesaler model, posting a $15 million net loss but signaling moderate EBITDA growth ahead.

nib Holdings reported a solid FY25 with underlying operating profit of $239.2 million and 3.2% policyholder growth, driven by digital innovation and operational efficiencies. The Group’s strategic focus on core health insurance and adjacent services sets the stage for continued momentum into FY26.